Skip to main content
Mobile menu expand icon
Menu
Close
About Gimv
Investment platforms
Anchor investments
Portfolio
Team
News
Investors
en
Search
*
(Optional)
Submit
About Gimv
Investment platforms
Anchor investments
Portfolio
Team
News
Investors
Sustainability
Working at/with Gimv
Contact
Search results Search results Search results
Search results
Search
*
(Optional)
Apply
1 - 690 of 952 results
Dirk Jonkman
Team member
See more info
Alro Group is taking an important step in its rapid growth as an e-mobility surface treatment specialist
Press release
See more info
Gatepost disclaimer
Page
Contains the disclaimer copy used in the Gatepost form.
See more info
Gimv leads CHF55.5M ($61M) Series A financing in Anjarium Biosciences to develop novel non-viral gene therapies.
Press release
See more info
Gimv invests in United Dutch Breweries, owner of iconic beer brand Oranjeboom
Press release
See more info
Gimv enters into a partnership with MVZ Holding, a leading group of medical practices
Press release
See more info
ImCheck to Present New Positive Data on ICT01 Monotherapy in Hematological Cancers at ESMO 2023
Press release
See more info
Mediar Therapeutics Announces Clinical Candidates for Lead Fibrosis Programs, Strategic Collaborations and Key Leadership Addition
Press release
See more info
Spineart has reached and surpassed €100M of revenue.
Press release
See more info
ImmunOs Therapeutics Announces Clinical Trial Collaboration with Merck & Co., Inc., Rahway, NJ, USA
Press release
See more info
Pagination
See more results